Successful start-up of Kemira's new production plant in Tarragona

At a glance

Kemira Oyj has begun production at its new coagulant plant in Tarragona, Spain. The plant will produce Kemira's aluminum and iron-based coagulants for drinking water and wastewater treatment. The plant is built on Bayer MaterialScience's site, ensuring a long-term partnership and access to raw materials. The Tarragona plant will be one of the largest coagulant manufacturing plants in EMEA, producing polyaluminum chloride, aluminum sulfate, and ferric chloride. This plant is an important step in consolidating Kemira's manufacturing footprint for coagulants in EMEA.

Kemira Oyj has successfully started up production in its new coagulant plant located in Tarragona, Spain. The plant is able to produce the entire range of Kemira's aluminum and iron-based coagulants that are used for drinking water and wastewater treatment.

Kemira's plant is built on Bayer MaterialScience's site securing sustainable access to raw material in a long term partnership. Kemira utilizes in its coagulant production hydrochloric acid that is a co-product derived from Bayer MaterialScience's production of methylene biphenyl diisocyanate (MDI).

The new Tarragona plant will be one of largest combined coagulant manufacturing plants in EMEA. Polyaluminum chloride (PAX), Aluminum sulfate (ALS) and Ferric chloride (PIX) will all be produced at the site and the capacity is instrumental in sustaining Kemira's leadership position in the municipal and industrial water treatment market in EMEA.

"The integration of our production facility and the partnership with Bayer MaterialScience in Tarragona provides us with crucial economic and environmental benefits.  And after the successful startup of the world scale coagulant plant in Dormagen, Germany last year, another major step is taken towards securing a competitive future with coagulants, in line with our strategy ", says Frank Wegener, President, Segment  Municipal & Industrial, Kemira Oyj.

The Tarragona plant is also an important step in consolidating Kemira's manufacturing footprint for coagulants in EMEA.